<P> Tuberculosis ( TB ) vaccines are vaccinations intended for the prevention of tuberculosis . Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch . Today , the only effective tuberculosis vaccine in common use is bacilli Calmette - Guérin ( BCG ) , first used in 1921 . About three out of every 10,000 people who get the vaccine experience side effects , which are usually minor except in severely immuno - depressed individuals . While BCG immunization provides fairly effective protection for infants and young children , ( including defence against TB meningitis and miliary TB ) , its efficacy in adults is variable , ranging from 0 % to 80 % . Several variables have been considered as responsible for the varying outcomes . Demand for TB immunotherapy advancement exists because the disease has become increasingly drug - resistant . </P>
<P> Tuberculosis ( TB ) vaccines are vaccinations intended for the prevention of tuberculosis . Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch . Today , the only effective tuberculosis vaccine in common use is bacilli Calmette - Guérin ( BCG ) , first used in 1921 . About three out of every 10,000 people who get the vaccine experience side effects , which are usually minor except in severely immuno - depressed individuals . While BCG immunization provides fairly effective protection for infants and young children , ( including defence against TB meningitis and miliary TB ) , its efficacy in adults is variable , ranging from 0 % to 80 % . Several variables have been considered as responsible for the varying outcomes . Demand for TB immunotherapy advancement exists because the disease has become increasingly drug - resistant . </P>
what is the name of the vaccine for tuberculosis
what is the name of the vaccine for tuberculosis
bacilli Calmette - Guérin ( BCG )
bacilli Calmette - Guérin ( BCG )